½Ä¹° À¯ÀüüÇÐ ½ÃÀå : À¯Çüº°, ±â¼úº°, Ư¼ºº°, ¿ëµµº°, Áö¿ªº°(2025-2033³â)
Plant Genomics Market Report by Type, Technology (DNA/RNA Sequencing, Genotyping, Marker-Assisted Selection, Bioinformatics, and Others), Trait, Application, and Region 2025-2033
»óǰÄÚµå
:
1675329
¸®¼Ä¡»ç
:
IMARC Group
¹ßÇàÀÏ
:
2025³â 03¿ù
ÆäÀÌÁö Á¤º¸
:
¿µ¹® 140 Pages
¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
¼¼°èÀÇ ½Ä¹° À¯ÀüüÇÐ ½ÃÀå ±Ô¸ð´Â 2024³â¿¡ 106¾ï ´Þ·¯¿¡ ´ÞÇß½À´Ï´Ù. ÇâÈÄ IMARC GroupÀº ½ÃÀåÀÌ 2033³â±îÁö 185¾ï ´Þ·¯¿¡ ´ÞÇϸç, 2025-2033³â¿¡ 6.01%ÀÇ ¼ºÀå·ü(CAGR)À» º¸ÀÏ °ÍÀ¸·Î ¿¹ÃøÇϰí ÀÖ½À´Ï´Ù.
½Ä¹° À¯ÀüüÇÐÀº ½Ä¹°ÀÇ Ç°ÁúÀ» °³¼±ÇÏ°í ½Ä¹°ÀÇ À¯ÀüÀû ±¸¼ºÀÌ ½Ä¹° À°Á¾¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â ¹æ¹ýÀ» °áÁ¤Çϱâ À§ÇØ »ç¿ëµÇ´Â ¼ö¸¹Àº À¯ÀüÀÚ Á¶ÀÛ ¹æ¹ýÀ» ¸»ÇÕ´Ï´Ù. ½Ä¹° À¯ÀüüÇÐÀÇ ¼ö¸¹Àº ¹ßÀüÀº ½Ä¹°ÀÇ ¸¶ÀÌÄÚÅå½Å ¿À¿°À» ¹æÁöÇϰí ÀÛ¹°ÀÌ ±ØÇÑÀÇ ±â¿ÂÀ» °ßµô ¼ö ÀÖµµ·Ï ÇÔÀ¸·Î½á ÀÛ¹° º¸È£¸¦ °³¼±ÇÒ ¼ö ÀÖ½À´Ï´Ù. ´õ »¡¸® ÀÚ¶ó´Â ½Ä¹°À» ÀÌ¿ëÇÒ ¼ö ÀÖ°Ô µÇ¸é ½Ä·®¾Èº¸ À¯Áö¿¡ ±â¿©ÇÏ°í ½ÃÀå¿¡ ¿µ¾çºÐÀ» ¾ÈÁ¤ÀûÀ¸·Î °ø±ÞÇÒ ¼ö ÀÖ°Ô µË´Ï´Ù. ½Ä¹° À¯ÀüüÇÐÀº ¶ÇÇÑ À¯ÀüÀÚ º¯Çü ÀÛ¹° °³¹ßÀ» ÅëÇØ Áúº´ÀÇ È®»êÀ» ¾ïÁ¦ÇÏ´Â µ¥ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù. ºÐÀÚÁø´ÜÇÐ, ºÐÀÚ¸¶Ä¿, À¯Àü°øÇÐ, Á¶Á÷¹è¾ç, À¯ÀÍÇÑ ¹Ì»ý¹°ÀÇ °³¹ßÀº ÀÛ¹°ÀÇ Ç°ÁúÀ» Çâ»ó½Ã۱â À§ÇØ Ã¤ÅÃµÈ À¯ÀüüÇÐÀÇ ÁÖ¿ä ºÐ¾ßÀÔ´Ï´Ù.
½Ä¹° À¯ÀüüÇÐ ½ÃÀå µ¿Çâ :
ÀÌ ½ÃÀåÀÇ ÁÖ¿ä ¿øµ¿·ÂÀº °³ÀÎµé »çÀÌ¿¡¼ ´Ü¹éÁú °áÇÌÁõÀÇ À¯º´·üÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ´Ü¹éÁúÀÌ Ç³ºÎÇÑ ½Ä¹°¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÀÌ ½ÃÀå¿¡¼´Â Àα¸ Áõ°¡¿¡ µû¶ó °íǰÁú °úÀÏ, ä¼Ò, °î¹°¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ¸¹Àº ÷´Ü ½Ä¹° À¯ÀüüÇÐ ±â¹ýÀ» °³¹ßÇϱâ À§ÇØ ¼öÇàµÇ°í ÀÖ´Â ±¤¹üÀ§ÇÑ ¿¬±¸°³¹ß(R&D) Ȱµ¿Àº ½ÃÀå¿¡ ´ëÇÑ ¹àÀº Àü¸ÁÀ» ¸¸µé¾î³»°í ÀÖ½À´Ï´Ù. À̿ʹ º°µµ·Î, °³·®µÈ ½Ä¹° ¹× ÀÛ¹° Àç¹è ÇÁ·Î±×·¥À» ÃßÁøÇÏ´Â ¿©·¯ ±¹°¡ÀÇ Á¤ºÎ ±â°üµéÀÇ È£ÀÇÀûÀÎ ³ë·ÂÀº ½ÃÀå¿¡ Ȱ·ÂÀ» ºÒ¾î³Ö°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ ½Ä»ý ÇǺ¹ÀÌ ±¤¹üÀ§ÇÏ°Ô ¼Õ½ÇµÊ¿¡ µû¶ó ½Ä»ýÀ» °³¼±ÇÏ°í ½Ä¹°ÀÇ »ý»ê¼ºÀ» ³ôÀ̱â À§ÇÑ ´ëü °úÇÐÀû ¹æ¹ýÀÌ ½ÃÇàµÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ ºñ¿ë È¿À²¼º ¹× ÀÚµ¿È ÀåºñÀÇ ºñ¿ë »ó½ÂÀ¸·Î ÀÎÇØ ÀÚµ¿È Àåºñº¸´Ù À¯ÀüüÇп¡ ´ëÇÑ ¼±È£µµ°¡ º¯ÈÇϰí ÀÖ´Â °Íµµ ½ÃÀåÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ½ÃÀå¿¡ ±â¿©ÇÏ´Â ´Ù¸¥ ¿äÀÎÀ¸·Î´Â ½Ä·®¾Èº¸¸¦ °³¼±Çϱâ À§ÇÑ ¹ÙÀÌ¿À °æÁ¦¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡, ±Þ¼ÓÇÑ µµ½ÃÈ, ½Äǰ ¹× À½·á(F&B) »ê¾÷ÀÇ »ó´çÇÑ ¼ºÀå, ä½ÄÁÖÀÇ µ¿Çâ Áõ°¡, Áö¼Ó°¡´ÉÇÑ °³¹ß¿¡ ´ëÇÑ °ü½É Áõ°¡ µîÀÌ ÀÖ½À´Ï´Ù.
ÀÌ º¸°í¼¿¡¼ ´Ù·é ÁÖ¿ä Áú¹®
- ¼¼°è ½Ä¹° À¯ÀüüÇÐ ½ÃÀåÀº Áö±Ý±îÁö ¾î¶»°Ô ÃßÀÌÇØ ¿Ô´Â°¡?
- COVID-19´Â ¼¼°è ½Ä¹° À¯ÀüüÇÐ ½ÃÀå¿¡ ¾î¶² ¿µÇâÀ» ¹ÌÃÆ´Â°¡?
- ÁÖ¿ä Áö¿ª ½ÃÀåÀº?
- À¯Çüº° ½ÃÀå ºÐ¼®Àº?
- ±â¼úº° ½ÃÀå ºÐ¼®Àº?
- Ư¼º¿¡ µû¸¥ ½ÃÀå ºÐ¼®Àº?
- ¿ëµµº° ½ÃÀå ºÐ¼®Àº?
- »ê¾÷ ¹ë·ùüÀÎÀÇ ´Ù¾çÇÑ ´Ü°è´Â?
- ¾÷°èÀÇ ÁÖ¿ä ÃËÁø¿äÀΰú °úÁ¦´Â?
- ¼¼°è ½Ä¹° À¯ÀüüÇÐ ½ÃÀåÀÇ ±¸Á¶¿Í ÁÖ¿ä ±â¾÷Àº?
- ¾÷°èÀÇ °æÀïÀº ¾î´À Á¤µµÀΰ¡?
¸ñÂ÷
Á¦1Àå ¼¹®
Á¦2Àå Á¶»ç ¹üÀ§¿Í Á¶»ç ¹æ¹ý
- Á¶»çÀÇ ¸ñÀû
- ÀÌÇØ°ü°èÀÚ
- µ¥ÀÌÅÍ ¼Ò½º
- ½ÃÀå ÃßÁ¤
- º¸ÅÒ¾÷ ¾îÇÁ·ÎÄ¡
- Åé´Ù¿î ¾îÇÁ·ÎÄ¡
- Á¶»ç ¹æ¹ý
Á¦3Àå °³¿ä
Á¦4Àå ¼·Ð
Á¦5Àå ¼¼°èÀÇ ½Ä¹° À¯ÀüüÇÐ ½ÃÀå
- ½ÃÀå °³¿ä
- ½ÃÀå ½ÇÀû
- COVID-19ÀÇ ¿µÇâ
- ½ÃÀå ¿¹Ãø
Á¦6Àå ½ÃÀå ³»¿ª : À¯Çüº°
- ºÐÀÚ °øÇÐ
- À¯ÀüÀÚ °øÇÐ
- À¯ÀüÀÚ ÆíÁý
- ±âŸ
Á¦7Àå ½ÃÀå ³»¿ª : ±â¼úº°
- DNA/RNA ½ÃÄö½Ì
- Áö³ëŸÀÌÇÎ
- MAS
- ¹ÙÀÌ¿ÀÀÎÆ÷¸Åƽ½º
- ±âŸ
Á¦8Àå ½ÃÀå ³»¿ª : Ư¼ºº°
- ¼ö·® Çâ»ó
- ³»º´¼º
- Á¦ÃÊÁ¦ ³»¼º
- ±âŸ
Á¦9Àå ½ÃÀå ³»¿ª : ¿ëµµº°
- °î¹°¡¤°î·ù
- Áö¹æ Á¾ÀÚ¡¤µÎ·ù
- °úÀÏ¡¤Ã¤¼Ò
- ±âŸ
Á¦10Àå ½ÃÀå ³»¿ª : Áö¿ªº°
- ºÏ¹Ì
- ¾Æ½Ã¾ÆÅÂÆò¾ç
- Áß±¹
- ÀϺ»
- Àεµ
- Çѱ¹
- È£ÁÖ
- Àεµ³×½Ã¾Æ
- ±âŸ
- À¯·´
- µ¶ÀÏ
- ÇÁ¶û½º
- ¿µ±¹
- ÀÌÅ»¸®¾Æ
- ½ºÆäÀÎ
- ·¯½Ã¾Æ
- ±âŸ
- ¶óƾ¾Æ¸Þ¸®Ä«
- Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
Á¦11Àå SWOT ºÐ¼®
Á¦12Àå ¹ë·ùüÀÎ ºÐ¼®
Á¦13Àå Porter's Five Forces ºÐ¼®
- °³¿ä
- ¹ÙÀ̾îÀÇ ±³¼··Â
- °ø±Þ ±â¾÷ÀÇ ±³¼··Â
- °æÀïÀÇ Á¤µµ
- ½Å±Ô ÁøÃâ¾÷üÀÇ À§Çù
- ´ëüǰÀÇ À§Çù
Á¦14Àå °¡°Ý ºÐ¼®
Á¦15Àå °æÀï ±¸µµ
- ½ÃÀå ±¸Á¶
- ÁÖ¿ä ±â¾÷
- ÁÖ¿ä ±â¾÷ÀÇ °³¿ä
- Agilent Technologies Inc.
- BGI Genomics
- Eurofins Scientific SE
- Floragenex Inc.
- GENEWIZ Inc.(Azenta Inc.)
- Illumina Inc.
- Keygene N.V.
- LC Sciences
- Neogen Corporation
- Novogene Co. Ltd.
- NRGene Technologies Ltd.
- Oxford Nanopore Technologies plc
- Qiagen N.V.
KSA
¿µ¹® ¸ñÂ÷
The global plant genomics market size reached USD 10.6 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 18.5 Billion by 2033, exhibiting a growth rate (CAGR) of 6.01% during 2025-2033.
Plant genomics refer to numerous genetic manipulation methods that are used to improve plant quality and aim to determine the manner genetic composition of plants affects plant breeding. With numerous advancements in plant genomics, crop protection may be improved by preventing mycotoxin contamination in plants and allowing crops to survive extreme temperatures. The availability of faster growing plants contributes to maintaining food security and ensuring that nutrients are available in the market. Plant genomics also plays an instrumental role in reducing the spread of diseases through the development of genetically modified crops. Molecular diagnostics, molecular markers, genetic engineering, tissue culture, and the development of beneficial microbes are the main areas of genomics that are employed to improve the quality of crops.
Plant Genomics Market Trends:
The market is majorly driven by the rising prevalence of protein deficiency among individuals, resulting in the augmenting demand for protein-rich plants. The market is experiencing an increase in the demand for fruit, vegetables, and cereals of high quality due to the increasing population. Also, extensive research and development (R&D) activities conducted for developing numerous advanced plant genomics methods are creating a positive outlook for the market. Apart from this, favorable initiatives taken by the government bodies of several countries promoting improved plant and crop growth programs are providing an impetus to the market. Additionally, the widespread loss of vegetative cover is resulting in the implementation of alternative scientific methods to improve vegetation and increase plant productivity. The market is further propelled by the shifting preference toward genomics over automated instruments due to its cost-efficiency and the growing costs of automated instruments. Some of the other factors contributing to the market include the escalating demand for a bio-based economy to improve food security, rapid urbanization, considerable growth in the food and beverage (F&B) industry, the rising trend of veganism and an enhanced focus on sustainable development.
Key Market Segmentation:
Breakup by Type:
- Molecular Engineering
- Genetic Engineering
- Genome Editing
- Others
Breakup by Technology:
- DNA/RNA Sequencing
- Genotyping
- Marker-Assisted Selection (MAS)
- Bioinformatics
- Others
Breakup by Trait:
- Yield Improvement
- Disease Resistance
- Herbicide Tolerance
- Others
Breakup by Application:
- Cereals and Grains
- Oilseeds and Pulses
- Fruits and Vegetables
- Others
Breakup by Region:
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Agilent Technologies Inc., BGI Genomics, Eurofins Scientific SE, Floragenex Inc., GENEWIZ Inc. (Azenta Inc.), Illumina Inc., Keygene N.V., LC Sciences, Neogen Corporation, Novogene Co. Ltd., NRGene Technologies Ltd., Oxford Nanopore Technologies plc and Qiagen N.V. Kindly, note that this only represents a partial list of companies, and the complete list has been provided in the report.
Key Questions Answered in This Report:
- How has the global plant genomics market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the global plant genomics market?
- What are the key regional markets?
- What is the breakup of the market based on the type?
- What is the breakup of the market based on the technology?
- What is the breakup of the market based on the trait?
- What is the breakup of the market based on the application?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global plant genomics market and who are the key players?
- What is the degree of competition in the industry?
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Plant Genomics Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Type
- 6.1 Molecular Engineering
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 Genetic Engineering
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
- 6.3 Genome Editing
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
- 6.4 Others
- 6.4.1 Market Trends
- 6.4.2 Market Forecast
7 Market Breakup by Technology
- 7.1 DNA/RNA Sequencing
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Genotyping
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
- 7.3 Marker-Assisted Selection (MAS)
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
- 7.4 Bioinformatics
- 7.4.1 Market Trends
- 7.4.2 Market Forecast
- 7.5 Others
- 7.5.1 Market Trends
- 7.5.2 Market Forecast
8 Market Breakup by Trait
- 8.1 Yield Improvement
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Disease Resistance
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
- 8.3 Herbicide Tolerance
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
- 8.4 Others
- 8.4.1 Market Trends
- 8.4.2 Market Forecast
9 Market Breakup by Application
- 9.1 Cereals and Grains
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
- 9.2 Oilseeds and Pulses
- 9.2.1 Market Trends
- 9.2.2 Market Forecast
- 9.3 Fruits and Vegetables
- 9.3.1 Market Trends
- 9.3.2 Market Forecast
- 9.4 Others
- 9.4.1 Market Trends
- 9.4.2 Market Forecast
10 Market Breakup by Region
- 10.1 North America
- 10.1.1 United States
- 10.1.1.1 Market Trends
- 10.1.1.2 Market Forecast
- 10.1.2 Canada
- 10.1.2.1 Market Trends
- 10.1.2.2 Market Forecast
- 10.2 Asia-Pacific
- 10.2.1 China
- 10.2.1.1 Market Trends
- 10.2.1.2 Market Forecast
- 10.2.2 Japan
- 10.2.2.1 Market Trends
- 10.2.2.2 Market Forecast
- 10.2.3 India
- 10.2.3.1 Market Trends
- 10.2.3.2 Market Forecast
- 10.2.4 South Korea
- 10.2.4.1 Market Trends
- 10.2.4.2 Market Forecast
- 10.2.5 Australia
- 10.2.5.1 Market Trends
- 10.2.5.2 Market Forecast
- 10.2.6 Indonesia
- 10.2.6.1 Market Trends
- 10.2.6.2 Market Forecast
- 10.2.7 Others
- 10.2.7.1 Market Trends
- 10.2.7.2 Market Forecast
- 10.3 Europe
- 10.3.1 Germany
- 10.3.1.1 Market Trends
- 10.3.1.2 Market Forecast
- 10.3.2 France
- 10.3.2.1 Market Trends
- 10.3.2.2 Market Forecast
- 10.3.3 United Kingdom
- 10.3.3.1 Market Trends
- 10.3.3.2 Market Forecast
- 10.3.4 Italy
- 10.3.4.1 Market Trends
- 10.3.4.2 Market Forecast
- 10.3.5 Spain
- 10.3.5.1 Market Trends
- 10.3.5.2 Market Forecast
- 10.3.6 Russia
- 10.3.6.1 Market Trends
- 10.3.6.2 Market Forecast
- 10.3.7 Others
- 10.3.7.1 Market Trends
- 10.3.7.2 Market Forecast
- 10.4 Latin America
- 10.4.1 Brazil
- 10.4.1.1 Market Trends
- 10.4.1.2 Market Forecast
- 10.4.2 Mexico
- 10.4.2.1 Market Trends
- 10.4.2.2 Market Forecast
- 10.4.3 Others
- 10.4.3.1 Market Trends
- 10.4.3.2 Market Forecast
- 10.5 Middle East and Africa
- 10.5.1 Market Trends
- 10.5.2 Market Breakup by Country
- 10.5.3 Market Forecast
11 SWOT Analysis
- 11.1 Overview
- 11.2 Strengths
- 11.3 Weaknesses
- 11.4 Opportunities
- 11.5 Threats
12 Value Chain Analysis
13 Porters Five Forces Analysis
- 13.1 Overview
- 13.2 Bargaining Power of Buyers
- 13.3 Bargaining Power of Suppliers
- 13.4 Degree of Competition
- 13.5 Threat of New Entrants
- 13.6 Threat of Substitutes
14 Price Analysis
15 Competitive Landscape
- 15.1 Market Structure
- 15.2 Key Players
- 15.3 Profiles of Key Players
- 15.3.1 Agilent Technologies Inc.
- 15.3.1.1 Company Overview
- 15.3.1.2 Product Portfolio
- 15.3.1.3 Financials
- 15.3.1.4 SWOT Analysis
- 15.3.2 BGI Genomics
- 15.3.2.1 Company Overview
- 15.3.2.2 Product Portfolio
- 15.3.2.3 Financials
- 15.3.3 Eurofins Scientific SE
- 15.3.3.1 Company Overview
- 15.3.3.2 Product Portfolio
- 15.3.3.3 Financials
- 15.3.3.4 SWOT Analysis
- 15.3.4 Floragenex Inc.
- 15.3.4.1 Company Overview
- 15.3.4.2 Product Portfolio
- 15.3.5 GENEWIZ Inc. (Azenta Inc.)
- 15.3.5.1 Company Overview
- 15.3.5.2 Product Portfolio
- 15.3.6 Illumina Inc.
- 15.3.6.1 Company Overview
- 15.3.6.2 Product Portfolio
- 15.3.6.3 Financials
- 15.3.6.4 SWOT Analysis
- 15.3.7 Keygene N.V.
- 15.3.7.1 Company Overview
- 15.3.7.2 Product Portfolio
- 15.3.8 LC Sciences
- 15.3.8.1 Company Overview
- 15.3.8.2 Product Portfolio
- 15.3.9 Neogen Corporation
- 15.3.9.1 Company Overview
- 15.3.9.2 Product Portfolio
- 15.3.9.3 Financials
- 15.3.9.4 SWOT Analysis
- 15.3.10 Novogene Co. Ltd.
- 15.3.10.1 Company Overview
- 15.3.10.2 Product Portfolio
- 15.3.11 NRGene Technologies Ltd.
- 15.3.11.1 Company Overview
- 15.3.11.2 Product Portfolio
- 15.3.11.3 Financials
- 15.3.12 Oxford Nanopore Technologies plc
- 15.3.12.1 Company Overview
- 15.3.12.2 Product Portfolio
- 15.3.12.3 Financials
- 15.3.12.4 SWOT Analysis
- 15.3.13 Qiagen N.V.
- 15.3.13.1 Company Overview
- 15.3.13.2 Product Portfolio
- 15.3.13.3 Financials
- 15.3.13.4 SWOT Analysis
Kindly, note that this only represents a partial list of companies, and the complete list has been provided in the report.
°ü·ÃÀÚ·á